Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.


Subscribe or Register

Existing user? Login

Hepatitis C

Advanced service to pay pharmacies £36 per point-of-care hepatitis C test delivered

Under a new service, pharmacies will be reimbursed for tests that are administered to people who inject drugs and who are not currently involved in community drug and alchohol treatment services.

Hepatitis C virus

Source: Science Photo Library

NHS England and NHS Improvement have said they are aiming to eliminate hepatitis C in England by 2025

Contractors in England will be reimbursed £36 for each point-of-care hepatitis C test performed as part of an advanced service, which will launch on 1 September 2020.

The service was first announced as part of the ‘Community Pharmacy Contractual Framework: 2019 to 2024’ in July 2019 and had been expected to start in April 2020, before being delayed by the COVID-19 pandemic.

The £36 reimbursement will be for tests administered to people who inject drugs, and who are not currently engaged in community drug and alcohol treatment services. Under the terms of the service, there will be no reimbursement if a test is provided to someone who falls outside of these eligibility criteria.

If the test is positive, the patient will be referred for further testing and treatment through a local Operational Delivery Network. These networks were established in 2015 and, according to the service specification, have treated around 50,000 patients with a 95% cure rate.

The community pharmacy testing service will initially run until 31 March 2022.

The service is time-limited because the national hepatis C testing programme is an “elimination exercise”, NHS England explained in the service specification. Prior to that date, the service will be reviewed and, if it is found to be effective, may be extended until later in 2022 or into 2023.

The UK is a signatory to the World Health Organization’s goal of eliminating hepatitis C by 2030. NHS England and NHS Improvement have said they aim to eliminate the virus in England by 2025.

Alastair Buxton, director of NHS services at the Pharmaceutical Services Negotiating Committee, said the commissioning of the service “provides an excellent opportunity for the sector to participate in an incredibly important national and global public health initiative to eliminate hepatitis C virus and the harm it causes to so many people in our society.

“In the UK, those at highest risk of contracting HCV [hepatitis C virus] are people who inject drugs, and community pharmacy is the healthcare provider with the best access to that group of people.”

In July 2020, NHS Tayside said it had become the first region in the world to effectively eliminate the virus. It had done this, it said, in part by targeting people who were currently using drugs, rather than those who had stopped and/or who were already accessing help.

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2020.20208312

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

  • Patient Care in Community Practice

    Patient Care in Community Practice

    Patient Care in Community Practice is a unique, practical guide for healthcare professionals or carers. Covers a range of non-medicinal products suitable for use at home.

    £22.00Buy now
  • Drugs of Abuse

    Drugs of Abuse

    A concise, easy-to-read guide for healthcare professionals who encounter drug abuse.

    £38.00Buy now
  • Pharmaceutical Toxicology

    Pharmaceutical Toxicology

    Explains the methodology and requirements of pre-clinical safety assessments of new medicines. Includes registration requirements and pharmacovigilance.

    £40.00Buy now
  • Adverse Drug Reactions

    Adverse Drug Reactions

    A practical guide to the drug reactions that affect particular organ systems, and the management of these reactions.

    £38.00Buy now
  • English Delftware Drug Jars

    English Delftware Drug Jars

    This beautiful book illustrates the art and history of the collection of English delftware drug jars in the Museum of the Royal Pharmaceutical Society of Great Britain.

    £54.00Buy now
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Jobs you might like

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.